Skip to Content

Pfizer 500 (Bosulif 500 mg)

Generic Name: bosutinib

Pill imprint Pfizer 500 has been identified as Bosulif 500 mg.

Bosulif is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Bosulif
Generic Name:
bosutinib
Imprint:
Pfizer 500
Strength:
500 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide